Patent for RSV vaccine using F protein trimer prefusion conformation
Summary
Patent for RSV vaccine using F protein trimer prefusion conformation
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IMMUNOGENIC COMPOSITIONS COMPRISING AN RSV F PROTEIN TRIMER
Application US20260097113A1 Kind: A1 Apr 09, 2026
Inventors
Bryan Mark Balthazor, Miguel Angel Garcia, Sumit Goswami, Lei Hu, Vamsi Krishna Mudhivarthi, Katherine Elizabeth Odneal, Shuai Shi, Serguei Tchessalov
Abstract
The invention relates to aqueous and lyophilized immunogenic compositions comprising an RSV F protein trimer in the prefusion conformation. The invention further relates to methods for storing an aqueous immunogenic composition comprising an RSV F protein trimer in the prefusion conformation as well as to methods for lyophilizing such aqueous immunogenic compositions.
CPC Classifications
A61K 39/155 A61K 9/08 A61K 9/19 A61K 47/02 A61K 47/183 A61K 47/26 A61K 2039/70 C12N 2760/18534
Filing Date
2023-09-26
Application No.
19115478
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.